Carol Taylor-Burds

Company: National Institute of Health Science

Job title: Program Director, Division of Translational Research

Seminars:

Panel Discussion: What Are the Requirements for Validating CNS Biomarkers for Use as Surrogate Endpoints? 8:15 am

Striving for consensus on what is considered a reliable and relevant biomarker of neurodegeneration or neuroinflammation Evaluating the ability of amyloid and NfL biomarkers to provide reliable measurements of therapeutic effects on disease neuropathology Defining fluid and imaging biomarker standards to be used in the clinicRead more

day: Conference Day One